Capital Raising Offer to Limited Parties, page-167

Yes, thats what i said
the issue is that BUBS hasn't identified the CNCA manufacturer who will register their formulation.....whilst they "have confidence the will make registration be end Q2".....based on what?

there is one other issue in that CFDA formulation registration will also take into consideration previous general import sales into china.......and BUBS dont have any (but then again either do wattle health).....CFDA formulation registration is basically at CFDA's discretion......and that is where Brilite MAY be able to help with some liberal Guanxi on the ground.......

The JD woman is irrelevant, as is Albert Tse.....they are nice Christmas baubles.....

i wish them luck, honestly. The more Australia companies developing business in china the better..